Skip to main content
NCBI home page
Gut logoLink to Gut
. 1984 Jan;25(1):73–78. doi: 10.1136/gut.25.1.73

Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.

P R Mills, A P Rae, D A Farah, R I Russell, A R Lorimer, D C Carter
PMCID: PMC1432238  PMID: 6360815

Abstract

The effects of different types of adrenoreceptor blocking agents on portal venous pressure were studied in patients with cirrhosis and portal hypertension. Oral atenolol (selective beta 1 blocker), propranolol (non-selective beta 1 and beta 2 blocker), and prazosin (alpha blocker) were compared in three groups of eight patients. Haemodynamic measurements were made before and after two or three and eight weeks of therapy. The dose of beta blockers was sufficient to reduce the exercise heart rate by more than 25%. Propranolol and prazosin produced a sustained reduction in the mean portohepatic venous pressure gradient of the order of 25% and 18% respectively. The cardiac index was significantly reduced by propranolol but not altered by prazosin. Atenolol produced an early reduction in portohepatic venous pressure which, although not sustained, showed a good correlation with reduction in cardiac index. No such relationship was found with propranolol. All three drugs were well tolerated by these patients with advanced cirrhosis. Therefore propranolol and prazosin have proved to be effective agents for the reduction of portal venous pressure.

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamsons R. J., Butt K., Dennis C. R., Kinkhabwala M., Moskowitz H., Gordon D., Babich A. Prognostic significance of portal pressure in patients with bleeding esophageal varices. Surg Gynecol Obstet. 1977 Sep;145(3):353–356. [PubMed] [Google Scholar]
  2. Boyer T. D., Triger D. R., Horisawa M., Redeker A. G., Reynolds T. B. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology. 1977 Apr;72(4 Pt 1):584–589. [PubMed] [Google Scholar]
  3. Branch R. A., James J., Read A. E. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. Br J Clin Pharmacol. 1976 Apr;3(2):243–249. doi: 10.1111/j.1365-2125.1976.tb00599.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colman J. C., Jennings G. L., McLean A. J., Mignot P. R., Dudley F. J. Propranolol in decompensated alcoholic cirrhosis. Lancet. 1982 Nov 6;2(8306):1040–1041. doi: 10.1016/s0140-6736(82)90067-8. [DOI] [PubMed] [Google Scholar]
  5. Conn H. O., Lindenmuth W. W., May C. J., Ramsby G. R. Prophylactic portacaval anastomosis. Medicine (Baltimore) 1972 Jan;51(1):27–40. doi: 10.1097/00005792-197201000-00002. [DOI] [PubMed] [Google Scholar]
  6. Conn H. O. The varix volcano connection. Gastroenterology. 1980 Dec;79(6):1333–1337. [PubMed] [Google Scholar]
  7. Forrester J. S., Ganz W., Diamond G., McHugh T., Chonette D. W., Swan H. J. Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J. 1972 Mar;83(3):306–311. doi: 10.1016/0002-8703(72)90429-2. [DOI] [PubMed] [Google Scholar]
  8. Granger D. N., Richardson P. D., Kvietys P. R., Mortillaro N. A. Intestinal blood flow. Gastroenterology. 1980 Apr;78(4):837–863. [PubMed] [Google Scholar]
  9. Hansen J. F., Hesse B., Christensen N. J. Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise. Eur J Clin Invest. 1978 Feb;8(1):31–36. doi: 10.1111/j.1365-2362.1978.tb00805.x. [DOI] [PubMed] [Google Scholar]
  10. Hillon P., Lebrec D., Muńoz C., Jungers M., Goldfarb G., Benhamou J. P. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis. Hepatology. 1982 Sep-Oct;2(5):528–531. doi: 10.1002/hep.1840020503. [DOI] [PubMed] [Google Scholar]
  11. Koch-Weser J., Graham R. M., Pettinger W. A. Drug therapy. Prazosin. N Engl J Med. 1979 Feb 1;300(5):232–236. doi: 10.1056/NEJM197902013000505. [DOI] [PubMed] [Google Scholar]
  12. Lebrec D., De Fleury P., Rueff B., Nahum H., Benhamou J. P. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980 Dec;79(6):1139–1144. [PubMed] [Google Scholar]
  13. Lebrec D., Nouel O., Corbic M., Benhamou J. P. Propranolol--a medical treatment for portal hypertension? Lancet. 1980 Jul 26;2(8187):180–182. doi: 10.1016/s0140-6736(80)90063-x. [DOI] [PubMed] [Google Scholar]
  14. Lebrec D., Poynard T., Hillon P., Benhamou J. P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med. 1981 Dec 3;305(23):1371–1374. doi: 10.1056/NEJM198112033052302. [DOI] [PubMed] [Google Scholar]
  15. MURRAY J. F., DAWSON A. M., SHERLOCK S. Circulatory changes in chronic liver disease. Am J Med. 1958 Mar;24(3):358–367. doi: 10.1016/0002-9343(58)90322-x. [DOI] [PubMed] [Google Scholar]
  16. McAinsh J., Baber N. S., Smith R., Young J. Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. Br J Clin Pharmacol. 1978 Aug;6(2):115–121. doi: 10.1111/j.1365-2125.1978.tb00835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richardson P. D., Withrington P. G. Liver blood flow. I. Intrinsic and nervous control of liver blood flow. Gastroenterology. 1981 Jul;81(1):159–173. [PubMed] [Google Scholar]
  18. Rubin P., Yee Y. G., Anderson M., Blaschke T. Prazosin first-pass metabolism and hepatic extraction in the dog. J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6):641–647. doi: 10.1097/00005344-197911000-00005. [DOI] [PubMed] [Google Scholar]
  19. Thorpe J. A. Effect of propranolol on the lower oesophageal sphincter in man. Curr Med Res Opin. 1980;7(2):91–95. doi: 10.1185/03007998009112032. [DOI] [PubMed] [Google Scholar]
  20. Yee Y. G., Rubin P. C., Meffin P. Prazosin determination by high-pressure liquid chromatography using fluorescence detection. J Chromatogr. 1979 Apr 21;172:313–318. doi: 10.1016/s0021-9673(00)90967-1. [DOI] [PubMed] [Google Scholar]
  21. Yee Y. G., Rubin P., Blaschke T. F. Atenolol determination by high-performance liquid chromatography and fluorescence detection. J Chromatogr. 1979 Apr 1;171:357–362. doi: 10.1016/s0021-9673(01)95315-4. [DOI] [PubMed] [Google Scholar]
  22. van Buuren H. R., van der Velden P. C., Koorevaar G., Silberbusch J. Propranolol increases arterial ammonia in liver cirrhosis. Lancet. 1982 Oct 30;2(8305):951–952. doi: 10.1016/s0140-6736(82)90158-1. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES